

Prof Frank Behrens
Professor Frank Behrens is Professor of Translational Rheumatology, Immunology and Inflammation Medicine and Head of the Inflammation Clinic, University Hospital, Frankfurt am Main, Germany, and Deputy Director, Fraunhofer Institute for Translational Medicine & Pharmacology (ITMP), Goethe University, Frankfurt am Main. He is also a member of the board of directors of the Fraunhofer Cluster of Excellence for Immune-Mediated Disease (CIMD).
Professor Behrens studied biology at the Johannes Gutenberg University in Mainz, Germany, before going on to study human medicine. He completed his doctorate in haematology and oncology before training in internal medicine and rheumatology.
Professor Behrens' main research interest is the pathophysiological understanding of spondyloarthritis, rheumatoid arthritis and mixed connected tissue disease. The focus is on understanding the links between these rheumatic conditions and associated skin and bowel diseases. The aim of the work is to develop new drug therapies and implement personalised treatment approaches using combined biomarker analyses and new imaging techniques. Since 2001, he has gained experience in clinical research and development as Principal Investigator, Chief Investigator and Managing Investigator. He is responsible for several investigator-initiated studies in rheumatic diseases.
Professor Behrens has published numerous articles in peer-reviewed journals and is author of several textbooks in the field of rheumatic diseases.
Professor Behrens is a member of various international committees and study groups such as the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), the Expert Panel Measures in Pulmonary Arterial Hypertension Related to Outcome of Systemic Sclerosis (EPOSS) and the Psoriatic Arthritis Genetic European Consortium (PAGE).
This session focuses on the pathobiological relationship between psoriasis and psoriatic arthritis (PsA), how transition from psoriasis to PsA occurs, as well as...
In this session, our speakers explore the inflammatory pathways in immune-mediated inflammatory disease in the context of the evolving treatment considerations...
Following a warm welcome by a senior UCB leader and our Summit Chairs, Plenary 1 examines how higher treatment targets can be met in patients with immune...
Dermatologists Dr. Álvaro González-Cantero, Dr. Annunziata Dattola and Dr. Nina Magnolo discuss how the materials on the Women and Psoriasis website can be used...
Expert advice and opinions from dermatologists on the importance of proactive and timely conversations about family planning and the potential impact on...
Use this discussion guide for women with psoriasis to empower them to raise sensitive issues with you to support personalized care.